目次

TABLE OF CONTENTS

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS CONSIDERED AND REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.3.5 STAKEHOLDERS
1.4 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
2.3.1.2 Approach 2: Customer-based market estimation
2.3.1.3 Approach 3: Top-down approach
2.3.1.4 Approach 4: Primary interviews
2.4 GROWTH FORECAST
2.5 DATA TRIANGULATION AND MARKET BREAKDOWN
2.6 MARKET SHARE ASSESSMENT
2.7 RESEARCH ASSUMPTIONS & LIMITATIONS
2.7.1 ASSUMPTIONS
2.7.2 LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ORTHOPEDIC DEVICES MARKET OVERVIEW
4.2 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT
4.3 EUROPE: ORTHOPEDIC DEVICES MARKET, BY SITE
4.4 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY END USER (USD MILLION)
4.5 ORTHOPEDIC DEVICES MARKET, BY REGION

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising cases of orthopedic diseases and disorders
5.2.1.2 Increasing adoption of telemedicine and telesurgery
5.2.1.3 Increasing demand for minimally invasive orthopedic surgical procedures
5.2.1.4 Growing number of sports and accident-related orthopedic injuries
5.2.1.5 Rising geriatric population and projected increase in age-related bone disorders
5.2.2 RESTRAINTS
5.2.2.1 Risks and complications associated with orthopedic surgical procedures
5.2.2.2 High cost of orthopedic devices and treatments
5.2.3 OPPORTUNITIES
5.2.3.1 Growing focus on orthobiologics
5.2.3.2 Rising number of hospitals and shift toward outpatient care
5.2.3.3 Increasing use of robotics and 3D printing in orthopedics
5.2.4 CHALLENGES
5.2.4.1 Dearth of orthopedic surgeons
5.3 ECOSYSTEM ANALYSIS
5.4 SUPPLY CHAIN ANALYSIS
5.4.1 MANUFACTURERS
5.4.1.1 Prominent companies
5.4.1.2 Small and medium-sized enterprises
5.4.2 END USERS
5.5 VALUE CHAIN ANALYSIS
5.5.1 RESEARCH AND DEVELOPMENT
5.5.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Robotic-assisted technology
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 Imaging systems and software
5.6.2.2 Fluoroscopy
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 AI and machine learning
5.7 KEY CONFERENCES AND EVENTS IN 2025-2026
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 902110
5.8.2 EXPORT DATA FOR HS CODE 902110
5.9 PATENT ANALYSIS
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.11 PORTER'S FIVE FORCES ANALYSIS
5.11.1 OVERVIEW
5.11.2 THREAT OF NEW ENTRANTS
5.11.3 THREAT OF SUBSTITUTES
5.11.4 BARGAINING POWER OF SUPPLIERS
5.11.5 BARGAINING POWER OF BUYERS
5.11.6 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS
5.12.2 KEY BUYING CRITERIA
5.13 CASE STUDY ANALYSIS
5.13.1 CASE STUDY 1: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE
5.13.2 CASE STUDY 2: EFFECTIVENESS OF OSTEOPATHY IN TREATING SPORTS INJURIES
5.13.3 CASE STUDY 3: TOTAL HIP REPLACEMENT WITH AVASCULAR NECROSIS
5.14 PRICING ANALYSIS
5.14.1 AVERAGE SELLING PRICE, BY REGION
5.14.2 AVERAGE SELLING PRICE, BY KEY PLAYER
5.15 REIMBURSEMENT SCENARIO
5.16 INVESTMENT & FUNDING SCENARIO
5.17 UNMET NEEDS AND KEY PAIN POINTS
5.18 REGULATORY LANDSCAPE
5.18.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.18.2 REGULATORY FRAMEWORK
5.18.2.1 North America
5.18.2.1.1 US
5.18.2.1.2 Canada
5.18.2.2 Europe
5.18.2.3 Asia Pacific
5.18.2.3.1 Japan
5.18.2.3.2 China
5.18.2.3.3 India
5.19 IMPACT OF AI ON ORTHOPEDIC DEVICES MARKET
5.20 ADVANCED PROSTHETICS
5.21 SMART IMPLANTS

6 ORTHOPEDIC DEVICES MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 ORTHOPEDIC REPLACEMENT DEVICES
6.2.1 FOOT & ANKLE REPLACEMENT DEVICES
6.2.1.1 Growing number of foot and ankle replacement procedures to fuel market growth
6.2.2 KNEE REPLACEMENT DEVICES
6.2.2.1 Ongoing innovation in knee implants to support growth
6.2.3 HIP REPLACEMENT DEVICES
6.2.3.1 Rising number of hip fractures and increasing success rate of hip arthroplasty to support market growth
6.2.4 HAND & WRIST REPLACEMENT DEVICES
6.2.4.1 Rising demand to support market growth
6.2.5 ELBOW REPLACEMENT DEVICES
6.2.5.1 Increasing frequency of elbow joint fractures and growth in elderly population to drive market
6.2.6 SHOULDER REPLACEMENT DEVICES
6.2.6.1 Launch of new shoulder replacement implants and rising popularity of reverse shoulder arthroplasty to support growth
6.2.7 OTHER REPLACEMENT DEVICES
6.3 SPINAL IMPLANTS & SURGICAL DEVICES
6.3.1 SPINAL FUSION DEVICES
6.3.1.1 Advantages of anterior thoracic & anterior lumbar fusion to support market growth
6.3.2 SPINAL NON-FUSION DEVICES
6.3.2.1 Increasing incidence of degenerative diseases in younger populations to drive market
6.4 ORTHOPEDIC FIXATION DEVICES
6.4.1 INTERNAL FIXATION DEVICES
6.4.1.1 Reduced incidence of malunion or nonunion of injured bones to support adoption
6.4.2 EXTERNAL FIXATION DEVICES
6.4.2.1 Increasing incidence of upper and lower-extremity injuries to drive market
6.5 ARTHROSCOPY INSTRUMENTS
6.5.1 RISING ARTHROSCOPY TREATMENT PROCEDURES TO SUPPORT MARKET GROWTH
6.6 ORTHOPEDIC BRACES & SUPPORTS
6.6.1 KNEE BRACES & SUPPORTS
6.6.1.1 Growing geriatric and obese populations to support market growth
6.6.2 ANKLE BRACES & SUPPORTS
6.6.2.1 Clinical benefits and favorable recommendations from physicians to support market growth
6.6.3 FOOT WALKERS & ORTHOSES
6.6.3.1 Rapidly growing diabetic population and subsequent rise in prevalence of foot problems to drive market
6.6.4 BACK, HIP, AND SPINE BRACES & SUPPORTS
6.6.4.1 Rising incidence of lower spine disorders to propel market
6.6.5 SHOULDER BRACES & SUPPORTS
6.6.5.1 Rising prevalence of shoulder arthritis to support market growth
6.6.6 ELBOW BRACES & SUPPORTS
6.6.6.1 Rising prevalence of elbow-related osteoarthritis to drive adoption
6.6.7 HAND & WRIST BRACES & SUPPORTS
6.6.7.1 Increasing incidence of hand and wrist injuries to drive market
6.6.8 FACIAL BRACES & SUPPORTS
6.6.8.1 Rising number of plastic surgeries to propel market
6.7 ORTHOPEDIC PROSTHETICS
6.7.1 SOLID ANKLE CUSHION HEEL PROSTHESES
6.7.1.1 Inexpensive, durable, and virtually maintenance-free properties to boost adoption
6.7.2 SINGLE-AXIAL PROSTHESES
6.7.2.1 Need for periodic servicing to limit adoption
6.7.3 MULTI-AXIAL PROSTHESES
6.7.3.1 High cost of multi-axial prostheses to limit market growth
6.7.4 DYNAMIC RESPONSE PROSTHESES
6.7.4.1 Low weight and support for active lifestyles to drive adoption
6.7.5 MICROPROCESSOR-CONTROLLED PROSTHESES
6.7.5.1 Higher stability and motion to support market growth
6.8 BONE GRAFT SUBSTITUTES
6.8.1 AUTOGRAFTS
6.8.1.1 High success rate in anterior and posterior cervical arthrodesis to support growth
6.8.2 ALLOGRAFTS
6.8.2.1 Reduced post-operative hospital stay coupled with limited requirement of incisions to drive market growth
6.8.3 SYNTHETIC GRAFTS
6.8.3.1 Reduced risk of disease transmission and high degree of customization to support market growth
6.9 ORTHOBIOLOGICS
6.9.1 VISCOSUPPLEMENTATION PRODUCTS
6.9.1.1 Cost-effectiveness of products to support market growth
6.9.2 DEMINERALIZED BONE MATRIX
6.9.2.1 Widespread acceptance in orthopedic surgery to fuel market growth
6.9.3 BONE MORPHOGENETIC PROTEINS
6.9.3.1 Osteoinductive properties and better integration in joint procedures to fuel market growth
6.9.4 PLASMA-RICH PROTEIN
6.9.4.1 Rising application of PRP in sports injuries to support market growth
6.9.5 BONE MARROW ASPIRATE CONCENTRATE
6.9.5.1 Minimally invasiveness procedure and less downtime to propel growth

7 ORTHOPEDIC DEVICES MARKET, BY PROCEDURE (VOLUME)

7.1 JOINT REPLACEMENT SURGERY PROCEDURAL VOLUME, BY SITE
7.2 ARTHROSCOPY PROCEDURAL VOLUME, BY SITE

8 ORTHOPEDIC DEVICES MARKET, BY SITE

8.1 INTRODUCTION
8.2 HAND & WRIST
8.2.1 RISING CASES OF RADIUS AND ULNA FRACTURES TO SUPPORT MARKET GROWTH
8.3 SPINE
8.3.1 TECHNOLOGICAL INNOVATIONS IN SPINAL IMPLANTS AND HIGHER INCIDENCE OF SPINAL SURGERY TO FUEL MARKET GROWTH
8.4 FOOT & ANKLE
8.4.1 RISING PREFERENCE FOR FOOT & ANKLE RECONSTRUCTION TO AUGMENT GROWTH
8.5 ARM & ELBOW
8.5.1 RISING INCIDENCE OF ARM FRACTURES TO ACCELERATE DEMAND FOR ORTHOPEDIC DEVICES
8.6 KNEE & THIGH
8.6.1 GROWING CASES OF COLLATERAL LIGAMENT INJURIES AND TENDON TEARS TO FUEL MARKET
8.7 HIP & PELVIS
8.7.1 RISING NUMBER OF PATIENTS UNDERGOING HIP REPLACEMENT SURGERY TO SUPPORT GROWTH
8.8 SHOULDER
8.8.1 INCREASING INCIDENCE OF SHOULDER INJURIES TO DRIVE MARKET
8.9 CRANIOMAXILLOFACIAL
8.9.1 INCREASING AWARENESS OF CRANIOMAXILLOFACIAL RECONSTRUCTIVE SURGERY TO PROPEL MARKET

9 ORTHOPEDIC DEVICES MARKET, BY APPLICATION

9.1 INTRODUCTION
9.2 FRACTURE TREATMENT & RECOVERY
9.2.1 RISING INCIDENCE OF FRACTURES TO BOOST DEMAND FOR ORTHOPEDIC DEVICES
9.3 SPINAL FUSION, FIXATION, AND DECOMPRESSION
9.3.1 GROWTH IN SPINAL FUSION SURGERIES TO DRIVE MARKET
9.4 RHEUMATOID ARTHRITIS & OSTEOARTHRITIS
9.4.1 RISING POOL OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS TO DRIVE MARKET
9.5 LIGAMENT INJURIES
9.5.1 INCREASING PARTICIPATION IN SPORTS AND PHYSICAL ACTIVITIES TO SUPPORT MARKET GROWTH
9.6 DIABETIC FOOT DISEASES
9.6.1 GROWING PREVALENCE OF DIABETIC FOOT ULCERS TO SUPPORT MARKET GROWTH
9.7 NEUROLOGICAL DISORDERS
9.7.1 RISING INCIDENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET

10 ORTHOPEDIC DEVICES MARKET, BY END USER

10.1 INTRODUCTION
10.2 HOSPITALS & SURGICAL CENTERS
10.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES COUPLED WITH INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
10.3 AMBULATORY CARE CENTERS & TRAUMA UNITS
10.3.1 COST-EFFECTIVE TREATMENT OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH
10.4 ORTHOPEDIC CLINICS
10.4.1 INCREASING NUMBER OF ORTHOPEDIC CLINICS TO SUPPORT MARKET GROWTH
10.5 HOME CARE SETTINGS
10.5.1 RISING PREFERENCE FOR HOME CARE TO SUSTAIN MARKET GROWTH
10.6 OTHER END USERS

11 ORTHOPEDIC DEVICES MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 US to dominate North American market
11.2.3 CANADA
11.2.3.1 Rising incidence of degenerative bone diseases to support market growth
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Germany to account for largest market share in Europe
11.3.3 FRANCE
11.3.3.1 Increasing prevalence of musculoskeletal disorders and significant adoption of orthopedic devices to support market growth
11.3.4 UK
11.3.4.1 Increasing awareness of orthopedic conditions to drive adoption of innovative treatments
11.3.5 ITALY
11.3.5.1 Increasing awareness of preventive care for musculoskeletal injuries to drive market
11.3.6 SPAIN
11.3.6.1 Growing preference for minimally invasive surgical procedures to drive market
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 JAPAN
11.4.2.1 Rapidly growing geriatric population to propel market
11.4.3 CHINA
11.4.3.1 Expanding target patient population to drive market
11.4.4 INDIA
11.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth
11.4.5 AUSTRALIA
11.4.5.1 Favorable government and private initiatives to promote market growth
11.4.6 SOUTH KOREA
11.4.6.1 Rising R&D and funding to drive market
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Strong presence of global players to drive market
11.5.3 MEXICO
11.5.3.1 Favorable investment scenario for medical device manufacturers to support market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Growing public-private partnerships to propel the market growth
11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2024)
12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Application footprint
12.5.5.5 Site footprint
12.5.5.6 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Competitive benchmarking of key startups/SMEs
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.7.1 COMPANY VALUATION
12.7.2 FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS

13 COMPANY PROFILES

13.1 KEY PLAYERS
13.1.1 ZIMMER BIOMET
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product approvals
13.1.1.3.2 Deals
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 STRYKER
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 JOHNSON & JOHNSON MEDTECH
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product launches & approvals
13.1.3.3.2 Deals
13.1.3.4 MnM view
13.1.3.4.1 Key strengths
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 SMITH+NEPHEW
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches & approvals
13.1.4.3.2 Deals
13.1.4.3.3 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses and competitive threats
13.1.5 B. BRAUN MELSUNGEN AG
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses and competitive threats
13.1.6 GLOBUS MEDICAL
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Product launches & approvals
13.1.6.3.2 Deals
13.1.7 ARTHREX, INC.
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product approvals
13.1.8 ENOVIS
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches & approvals
13.1.8.3.2 Deals
13.1.8.3.3 Expansions
13.1.9 ACUMED LLC
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.9.3 Recent developments
13.1.9.3.1 Product launches
13.1.9.3.2 Deals
13.1.9.3.3 Expansions
13.1.10 ORTHOFIX MEDICAL INC.
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 Recent developments
13.1.10.3.1 Product launches & approvals
13.1.10.3.2 Deals
13.1.11 MICROPORT SCIENTIFIC CORPORATION
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Product launches & approvals
13.1.11.3.2 Deals
13.1.12 CONMED CORPORATION
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.13 PARAGON 28, INC.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 Recent developments
13.1.13.3.1 Product launches & approvals
13.1.13.3.2 Deals
13.1.14 MEDACTA INTERNATIONAL
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.14.3 Recent developments
13.1.14.3.1 Product launches & approvals
13.1.14.3.2 Deals
13.1.14.3.3 Expansions
13.1.15 MERIL LIFE SCIENCES PVT. LTD.
13.1.15.1 Business overview
13.1.15.2 Products offered
13.1.15.3 Recent developments
13.1.15.3.1 Expansions
13.1.16 MAXX ORTHOPEDICS, INC.
13.1.16.1 Business overview
13.1.16.2 Products offered
13.1.16.3 Recent developments
13.1.16.3.1 Product approvals
13.1.16.3.2 Deals
13.2 OTHER PLAYERS
13.2.1 FH ORTHO
13.2.2 SYMBIOS ORTHOPEDIE S.A.
13.2.3 MADISON ORTHO
13.2.4 GREEN SURGICALS PVT. LTD.
13.2.5 SIORA SURGICAL PVT. LTD.
13.2.6 ORTHOPEDIATRICS CORP.
13.2.7 RESTOR3D
13.2.8 DOUBLE MEDICAL TECHNOLOGY INC.
13.2.9 TREACE MEDICAL CONCEPTS, INC.
13.2.10 AK MEDICAL

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS